How should I compute insulin dosing and make adjustments using weight‑based total daily dose, basal‑bolus split, insulin‑to‑carbohydrate ratio, and correction factor for a patient with type 1 or type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dosing Computation and Adjustment

Weight‑Based Total Daily Dose (TDD) Calculation

For type 1 diabetes, start with 0.5 units/kg/day as the standard initial TDD for metabolically stable patients, with an acceptable range of 0.4–1.0 units/kg/day. 1

  • Higher doses (up to 1.5 units/kg/day) are required during puberty, pregnancy, or acute illness 1
  • Patients in the honeymoon phase or with residual beta‑cell function may need only 0.2–0.6 units/kg/day 1

For type 2 diabetes initiating insulin, begin with 10 units once daily or 0.1–0.2 units/kg/day of basal insulin. 2, 1

  • For severe hyperglycemia (HbA1c ≥9% or glucose ≥300 mg/dL), start with 0.3–0.5 units/kg/day split between basal and prandial insulin 1
  • Type 2 patients typically require ≥1 unit/kg/day total due to insulin resistance 1

Basal‑Bolus Split

Allocate approximately 40–60% of TDD to basal insulin and 50–60% to prandial insulin in type 1 diabetes on multiple daily injections. 1, 3

  • For type 2 diabetes starting basal insulin alone, begin with 50% of TDD as basal and add prandial insulin only when basal exceeds 0.5 units/kg/day without achieving targets 2, 1
  • In insulin pump therapy, basal delivery comprises approximately 40–60% of TDD, with the remainder as mealtime and correction boluses 1

Research evidence suggests basal requirements may be lower than traditionally taught: prospective CGM studies found optimal basal insulin averaged only 27–30% of TDD when properly titrated to avoid hypoglycemia 4, 5, though guideline recommendations remain at 40–50% 2, 1

Insulin‑to‑Carbohydrate Ratio (ICR)

Calculate ICR using the formula: ICR = 450 ÷ TDD for rapid‑acting insulin analogs (lispro, aspart, glulisine). 1

  • For regular insulin, use ICR = 500 ÷ TDD 1
  • Example: A patient on 45 units TDD would have an ICR of 1 unit per 10 grams carbohydrate (450 ÷ 45 = 10) 1

ICR exhibits significant diurnal variation—breakfast typically requires more insulin per gram of carbohydrate due to counter‑regulatory hormones (cortisol, growth hormone). 1, 4

  • Research using CGM titration found breakfast ICR = 300 ÷ TDD, while lunch and dinner ICR = 400 ÷ TDD 4
  • This means a patient on 30 units TDD would need 1 unit per 10g carbs at breakfast but only 1 unit per 13g carbs at lunch/dinner 4
  • The traditional 450 or 500 formulas may underestimate insulin needs, particularly at breakfast 6, 7, 4

Adjust the ICR if post‑prandial glucose consistently misses target: if 2‑hour post‑meal glucose is not within ±20% of pre‑meal glucose, tighten the ratio (e.g., from 1:10 to 1:8). 1, 7

Correction Factor (Insulin Sensitivity Factor)

Calculate correction factor using: CF = 1500 ÷ TDD for rapid‑acting insulin analogs. 1

  • For regular insulin, use CF = 1700 ÷ TDD 1
  • Example: A patient on 50 units TDD would have a CF of 30 mg/dL per unit (1500 ÷ 50 = 30) 1

The correction dose is calculated as: (Current glucose – Target glucose) ÷ CF. 1

  • If current glucose is 250 mg/dL, target is 120 mg/dL, and CF is 30, give (250 – 120) ÷ 30 = 4.3 units, rounded to 4 units 1

Research suggests the traditional 1700 formula may underestimate correction needs: prospective CGM studies found CF = (1076 ÷ TDD) + 12 more accurately matched observed results 7, though guideline recommendations remain at 1500 ÷ TDD 1

There is a highly significant mathematical relationship between ICR and CF: ICR × 4.5 = CF. 6, 7, 8

  • This means if your ICR is 10, your CF should be approximately 45 mg/dL per unit 6, 7
  • Any change in one factor may require adjustment of the other 7

Practical Dosing Algorithm

Step 1: Calculate Initial TDD

  • Type 1 diabetes: 0.5 units/kg/day 1
  • Type 2 diabetes (insulin‑naïve): 10 units or 0.1–0.2 units/kg/day 2, 1
  • Type 2 diabetes (severe hyperglycemia): 0.3–0.5 units/kg/day 1

Step 2: Split Between Basal and Prandial

  • Type 1 diabetes: 40–50% basal, 50–60% prandial 1, 3
  • Type 2 diabetes: Start with basal only; add prandial when basal exceeds 0.5 units/kg/day 2, 1

Step 3: Calculate ICR and CF

  • ICR = 450 ÷ TDD (or use 300 for breakfast, 400 for lunch/dinner based on research) 1, 4
  • CF = 1500 ÷ TDD 1
  • Verify relationship: ICR × 4.5 should approximately equal CF 6, 7, 8

Step 4: Titrate Based on Glucose Patterns

  • Basal insulin: Increase by 2 units every 3 days if fasting glucose 140–179 mg/dL; increase by 4 units every 3 days if fasting ≥180 mg/dL 2, 1
  • Prandial insulin: Adjust each meal dose by 1–2 units (10–15%) every 3 days based on 2‑hour post‑prandial glucose 1
  • ICR adjustment: If post‑prandial glucose consistently misses target, tighten or loosen the ratio 1, 7
  • CF adjustment: If correction doses fail to bring glucose into target range, recalculate CF 1

Critical Thresholds and Safety Limits

Stop escalating basal insulin when the dose approaches 0.5–1.0 units/kg/day without achieving glycemic targets; add prandial insulin instead to avoid "over‑basalization." 2, 1

  • Clinical signals of over‑basalization include: basal dose >0.5 units/kg/day, bedtime‑to‑morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability 1

Reduce any insulin dose by 10–20% immediately if unexplained hypoglycemia (glucose <70 mg/dL) occurs. 1, 3

Recalculate TDD, ICR, and CF periodically (every few weeks to months), not daily—these are structural parameters that change with overall insulin sensitivity, not meal‑to‑meal variations. 1

Common Pitfalls to Avoid

Do not use sliding‑scale insulin as monotherapy—it must supplement a scheduled basal‑bolus regimen, never replace it. 2, 1

Do not administer rapid‑acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk. 1

Do not continue escalating basal insulin beyond 0.5–1.0 units/kg/day without addressing post‑prandial hyperglycemia with prandial insulin. 2, 1

Recognize that traditional formulas (450/500 for ICR, 1500/1700 for CF) may underestimate insulin needs: prospective CGM research consistently found patients required more bolus insulin than these formulas predict 6, 7, 4, though guidelines have not yet updated these recommendations 2, 1

For underweight patients or those at high hypoglycemia risk, use the lower end of dosing ranges (0.1–0.25 units/kg/day) and aim for the middle of target glucose ranges rather than the lower boundary. 1, 3

References

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

(7) approaches to glycemic treatment.

Diabetes Care, 2015

Guideline

Management of Type 1 Diabetes with Overnight Hypoglycemia Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2010

Research

How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2012

Related Questions

What insulin-to-carbohydrate ratio and correction factor should be used for a type 1 diabetic with a total daily insulin dose of 66 units?
Given a current breakfast insulin-to-carbohydrate ratio of 1 U per 2.6 g and a post-breakfast blood glucose of 49 mg/dL, what should the breakfast insulin-to-carbohydrate ratio be adjusted to?
What should be the basal insulin glargine (Lantus) dose, insulin‑to‑carbohydrate ratio (ICR), and insulin sensitivity factor (ISF) for a 40‑year‑old man with type 1 diabetes, weight 73 kg, chronic kidney disease (creatinine 1.24 mg/dL, eGFR ≈ 75 mL/min) and a small acute kidney injury, who is on Lantus 14 U and fixed‑meal insulin lispro (Novolog) 18 U breakfast, 14 U lunch, 10 U dinner, received dexamethasone 48 hours ago, and required 2.5 U via IV insulin drip?
Would a 40% reduction in insulin dose correspond to an insulin-to-carbohydrate ratio of 1 unit per 8 g of carbohydrate?
For a 46‑year‑old man with type 3c diabetes, weight 88 kg, creatinine 1.18 mg/dL (eGFR ≈ 77 mL/min) on Lantus (insulin glargine) 10 U daily, insulin‑to‑carbohydrate ratio 10 g per unit, insulin sensitivity factor 50 mg/dL per unit, with capillary glucose 263 mg/dL at 1700 h, 231 mg/dL at 0200 h, and 284 mg/dL at 0700 h after meals of 80 g, 82 g, and 34 g carbohydrates, what should the basal insulin dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
How should hypercalcemia be managed in a patient with chronic kidney disease who is taking calcium‑based phosphate binders and vitamin D analogues (e.g., paricalcitol, calcitriol)?
In a patient with a low transphincteric anal fistula involving about 30 % of the external sphincter, should I perform a fistulotomy rather than place a seton?
What are the potential adverse effects of high‑flow oxygen therapy in adult emergency department patients, especially those with chronic obstructive pulmonary disease or other hypercapnic respiratory disorders?
What does preserved liver function mean in the Barcelona‑Clinic Liver Cancer (BCLC) staging system?
Are cold sores (herpes simplex virus type 1 infections) considered a sexually transmitted disease?
How should Rowatinex be prescribed for an adult patient with renal colic or urinary stone passage, including dose, duration, contraindications, and monitoring?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.